REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $680,374 | +0.4% | 24,580 | -3.0% | 0.00% | – |
| Q2 2023 | $677,578 | +38.7% | 25,330 | +12.3% | 0.00% | – |
| Q1 2023 | $488,585 | +9.3% | 22,557 | +20.2% | 0.00% | – |
| Q4 2022 | $447,126 | +35.9% | 18,771 | +12.6% | 0.00% | – |
| Q3 2022 | $329,000 | +34.3% | 16,672 | +32.4% | 0.00% | – |
| Q2 2022 | $245,000 | +15.0% | 12,590 | +51.0% | 0.00% | – |
| Q1 2022 | $213,000 | -4.1% | 8,335 | -5.3% | 0.00% | – |
| Q4 2021 | $222,000 | -43.7% | 8,805 | -38.6% | 0.00% | – |
| Q3 2021 | $394,000 | -48.0% | 14,339 | -40.0% | 0.00% | – |
| Q2 2021 | $758,000 | -30.5% | 23,889 | +0.5% | 0.00% | -100.0% |
| Q1 2021 | $1,090,000 | +17.7% | 23,761 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $926,000 | +356.2% | 23,387 | +301.7% | 0.00% | – |
| Q3 2020 | $203,000 | – | 5,822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |